Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. September 2015 10:30 ET | Quelle: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at the Rodman & Renshaw(R) 17th Annual Global Investment Conference

RANCHO CORDOVA, Calif., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today announced that Ken Harris, President of...
10. September 2015 06:00 ET | Quelle: Cesca Therapeutics Inc.

Cesca Therapeutics to Announce Fourth Quarter and Fiscal 2015 Year End Results on September 17, 2015

RANCHO CORDOVA, Calif., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, announced today it will report financial...
01. September 2015 09:05 ET | Quelle: Cesca Therapeutics Inc.

Cesca Therapeutics Secures $15 Million Financing From Institutional Life Sciences Fund

RANCHO CORDOVA, Calif., Sept. 1, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced the signing and initial closing...
25. Juni 2015 06:00 ET | Quelle: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Compliance With Nasdaq Stock Market Under Listing Rule 5250(c)(1)

RANCHO CORDOVA, Calif., June 25, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics, Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company has received...
23. Juni 2015 16:05 ET | Quelle: Cesca Therapeutics Inc.

Cesca Therapeutics Reports Third Quarter Fiscal 2015 Results

Company Receives US FDA Approval for Its IDE Submission to the FDA for a Phase III Pivotal Clinical Trial for the Treatment of Patients With Critical Limb Ischemia (CLI) Management Will Hold a...
23. Juni 2015 06:00 ET | Quelle: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Issuance of New U.S. Patent

RANCHO CORDOVA, Calif., June 23, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics, Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today announced the issuance of U.S. Patent...
17. Juni 2015 06:00 ET | Quelle: Cesca Therapeutics Inc.

Cesca Therapeutics to Announce Third Quarter Fiscal 2015 Results on June 23, 2015

RANCHO CORDOVA, Calif., June 17, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, announced today it will report financial...
16. Juni 2015 06:00 ET | Quelle: Cesca Therapeutics Inc.

Cesca Therapeutics Receives FDA IDE Approval for U.S. Pivotal Clinical Trial in Critical Limb Ischemia

RANCHO CORDOVA, Calif., June 16, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today announced that the U.S. Food and Drug...
12. Juni 2015 06:00 ET | Quelle: Cesca Therapeutics Inc.

Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer

RANCHO CORDOVA, Calif., June 12, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, announced today the appointment of Robin C....
01. Juni 2015 06:00 ET | Quelle: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Marcum LLP as the Company's New Independent Registered Public Accounting Firm

RANCHO CORDOVA, Calif., June 1, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today announced that the Company has appointed...

Vorherige Seite